Mostrar el registro sencillo del ítem

dc.contributor.author
Hendrix, James A.  
dc.contributor.author
Finger, Brad  
dc.contributor.author
Weiner, Michael W.  
dc.contributor.author
Frisoni, Giovanni B.  
dc.contributor.author
Iwatsubo, Takeshi  
dc.contributor.author
Rowe, Christopher C.  
dc.contributor.author
Kim, Seong Yoon  
dc.contributor.author
Guinjoan, Salvador Martín  
dc.contributor.author
Sevlever, Gustavo  
dc.contributor.author
Carrillo, Maria Cristina  
dc.date.available
2017-05-03T22:13:40Z  
dc.date.issued
2015-07  
dc.identifier.citation
Hendrix, James A.; Finger, Brad; Weiner, Michael W.; Frisoni, Giovanni B.; Iwatsubo, Takeshi; et al.; The worldwide Alzheimer's disease neuroimaging initiative: an update; Elsevier Inc; Alzheimers & Dementia; 11; 7; 7-2015; 850-859  
dc.identifier.issn
1552-5260  
dc.identifier.uri
http://hdl.handle.net/11336/15955  
dc.description.abstract
The Alzheimer's Disease Neuroimaging Initiative (ADNI), launched in 2004, has worked to accelerate drug development by validating imaging and blood/cerebrospinal fluid biomarkers for Alzheimer's disease clinical treatment trials. ADNI is a naturalistic (nontreatment) multisite longitudinal study. A true public-private partnership, the initiative has set a new standard for data sharing without embargo and for the use of biomarkers in dementia research. The ADNI effort in North America is not the only such effort in the world. The Alzheimer's Association recognized these global efforts and formed Worldwide ADNI (WW-ADNI). By creating a platform for international collaboration and cooperation, WW-ADNI's goals are to harmonize projects and results across geographical regions and to facilitate data management and availability to investigators around the world. WW-ADNI projects include those based in North America, Europe, Japan, Australia, Korea, and Argentina.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier Inc  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/  
dc.subject
Alzheimer'S Disease  
dc.subject
Neuroimaging  
dc.subject
Biomarkers  
dc.subject
Cerebrospinal Fluid  
dc.subject.classification
Psiquiatría  
dc.subject.classification
Medicina Clínica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
The worldwide Alzheimer's disease neuroimaging initiative: an update  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2017-04-28T17:10:35Z  
dc.journal.volume
11  
dc.journal.number
7  
dc.journal.pagination
850-859  
dc.journal.pais
Estados Unidos  
dc.description.fil
Fil: Hendrix, James A.. Alzheimer's Association; Estados Unidos  
dc.description.fil
Fil: Finger, Brad.  
dc.description.fil
Fil: Weiner, Michael W.. University of California; Estados Unidos  
dc.description.fil
Fil: Frisoni, Giovanni B.. Universidad de Ginebra; Suiza  
dc.description.fil
Fil: Iwatsubo, Takeshi. University Hospital of Tokyo. Graduate School of Medicine. Department of Neuropathology; Japón  
dc.description.fil
Fil: Rowe, Christopher C.. Austin Health. Department of Molecular Imaging; Australia  
dc.description.fil
Fil: Kim, Seong Yoon. Asian Medical Center. Department of Psychiatry; Corea del Sur  
dc.description.fil
Fil: Guinjoan, Salvador Martín. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Sevlever, Gustavo. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina  
dc.description.fil
Fil: Carrillo, Maria Cristina. Alzheimer's Association; Estados Unidos  
dc.journal.title
Alzheimers & Dementia  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S1552526015001752  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.jalz.2015.05.008